
MOPH states the effectiveness of Covid-19 vaccines in preventing severe infection

The local and International clinical evidence shows that COVID-19 vaccines and particularly the use of booster doses are significantly effective in preventing severe infection, highlighted by The Ministry of Public Health (MOPH).
Dr. Abdullatif Al Khal, Chair of the National Health Strategic Group on COVID-19 and Head of Infectious Diseases at Hamad Medical Corporation, stated that based on the clinical research in Qatar and around the world, the booster dose has a 75% protection against mild to moderate infection and more than 90% against severe infection or death. These high levels of immunity have impacted the number of hospital admissions in Qatar.
"The high level of immunity offered by the vaccines is obvious when it comes to COVID-19 patients who are experiencing the most severe symptoms. There have sadly been seven recent deaths in Qatar due to COVID-19 and none of these individuals had received any of their COVID-19 vaccine doses. Additionally, almost all patients admitted to intensive care units are either unvaccinated or had their second dose of the vaccine more than 6 months ago. It is noteworthy that there have been almost no ICU admissions among those who received their booster dose," said Dr. Al Khal.
"Getting vaccinated, and notably getting the booster dose, will significantly increase the individual immunity against all COVID-19 variants, including Omicron. Individuals who received their second dose within the last 6 months will have good levels of immunity but from this point onwards their protection declines. Therefore, it is extremely important for people to get their booster dose as soon as they become eligible, 6 months after their second dose," he added.
The vaccines provide stronger and enduring immunity than natural infection. Also, anyone is eligible for the booster if they had received their second vaccine more than six months ago. The pace of providing booster doses is smooth, with more than 368,000 booster vaccine doses in Qatar, only a few individuals have reported side effects. However, they are identical to the second vaccine. It includes low-grade fever, fatigue, soreness at the injection area, and mild headache. MOPH has not received any reports with serious side effects, said Dr. Al Khal.
--
Make sure to check out our social media to keep track of the latest content.
Instagram - @qatarliving
Twitter - @qatarliving
Facebook - Qatar Living
YouTube - qatarlivingofficial
Cover image credit & source: Peninsula